Switching among antipsychotics in everyday clinical practice: focus on ziprasidone.
about
Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations.Evidence review and clinical guidance for the use of ziprasidone in Canada.Practical guidance for prescribing ziprasidone in acute manic or mixed episodes of bipolar I disorder.Metabolic and cardiovascular adverse effects associated with antipsychotic drugs.Switching to ziprasidone in the clinical practice setting: an open-label study.
P2860
Switching among antipsychotics in everyday clinical practice: focus on ziprasidone.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Switching among antipsychotics in everyday clinical practice: focus on ziprasidone.
@en
Switching among antipsychotics in everyday clinical practice: focus on ziprasidone.
@nl
type
label
Switching among antipsychotics in everyday clinical practice: focus on ziprasidone.
@en
Switching among antipsychotics in everyday clinical practice: focus on ziprasidone.
@nl
prefLabel
Switching among antipsychotics in everyday clinical practice: focus on ziprasidone.
@en
Switching among antipsychotics in everyday clinical practice: focus on ziprasidone.
@nl
P2093
P2860
P356
P1476
Switching among antipsychotics in everyday clinical practice: focus on ziprasidone.
@en
P2093
Christoph U Correll
Fernando Cañas
Georgios Papageorgiou
Ilkka Larmo
José Manuel Montes
Mathias Zink
Pedro Levy
Runa Sturlason
P2860
P304
P356
10.3810/PGM.2011.01.2255
P407
P577
2011-01-01T00:00:00Z